[ad_1] Boxes of Novo Nordisk’s weight-loss drug Wegovy in Oslo, Norway, Nov. 21, 2023. Victoria Klesty | Reuters Danish drugmaker Novo Nordisk‘s parent company, Novo Holdings, on Monday said it will acquire drug manufacturer Catalent in a $16.5 billion deal that could help boost the supply of the highly popular weight loss injection Wegovy and…
[ad_1] Sopa Images | Lightrocket | Getty Images Eli Lilly is shaking up the pharmaceutical industry with a new website offering telehealth prescriptions and direct home delivery of certain drugs, including its red-hot weight loss treatment Zepbound, to expand patient access. The company’s direct-to-consumer push announced Thursday, the first of its kind for a big…
[ad_1] As temperature dips and the holiday spirit pervades the atmosphere, all you want to do is enjoy those tempting delicacies including cakes, pastries and hot chocolate, and bundle up in a cosy space in your home. Even when we are forced to go about our daily duties, physical activities take a backseat in the…
[ad_1] George Frey | Bloomberg | Getty Images Weight loss drugs exploded into the public eye this year, and 2024 will bring more change to the evolving market. The drugs skyrocketed in popularity in 2023 as they helped patients shed significant weight, despite hefty price tags, mixed insurance coverage and a handful of unpleasant side…
[ad_1] CFOTO | Future Publishing | Getty Images Pfizer on Friday said it would stop developing the twice-daily version of its experimental weight loss pill after obese patients taking the drug lost weight but had trouble tolerating the drug in a mid-stage clinical study. The drugmaker observed high rates of adverse side effects, which were…
[ad_1] Weight influences how and at what time bodies burn energy, shows a new research. The study published in the journal ‘Obesity’ found people who have a healthy weight use more energy during the day, when most people are active and eat, while those who have obesity spend more energy during the night, when most…
[ad_1] Eli Lilly and Company, Pharmaceutical company headquarters in Alcobendas, Madrid, Spain. Cristina Arias | Cover | Getty Images Eli Lilly on Thursday reported third-quarter revenue and adjusted earnings that topped estimates on strong demand for its diabetes drug Mounjaro, but slashed its full-year profit guidance due to charges primarily related to its recent acquisitions….
[ad_1] A time of joy, celebration, and indulgence is what the holiday season is all about. It’s a time of year when there are many family get-togethers, feasts, and parties, and it’s simple to overindulge in the delicious treats and fatty foods that are everywhere. While it’s important to make the most of this time,…
[ad_1] Weight loss has always been big business, but it’s exploded of late due to surging demand for Ozempic, Wegovy and other new diabetes and obesity drugs. In the first half of 2023, sales of Ozempic and Wegovy rose by 58% and 363%, respectively. That’s after quarterly prescriptions for those types of GLP-1 treatments, which mimic…
[ad_1] In the quest for a slimmer waistline and a healthier lifestyle, yoga has emerged as a powerful tool. This ancient practice not only enhances flexibility and promotes mental well-being but can also be highly effective in reducing stubborn belly fat. By engaging various muscle groups and encouraging mindful eating, yoga can contribute to a…
